Additional information
| Active substance | Silodosin |
|---|---|
| Water Retention | Minimal to none |
| Hepatotoxicity | Low |
| Lab Test | Not specific |
| Also known as | KMD-3213 |
| Blood pressure | May cause a decrease in blood pressure |
| Trade name | Rapaflo, Silodyx |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | 1-(3-Hydroxypropyl)-5-[(2R)-2-({2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl}amino)propyl]-2,3-dihydro-1H-indole-7-carboxamide |
| Formula | C25H32F3N3O4 |
| Substance class | Alpha-1 adrenergic receptor antagonist |
| Main action | Reduces smooth muscle contraction in the prostate and urethra |
| Half-life | Approximately 13 hours |
| Dosage (medical) | Typically 8 mg once daily |
| Dosage (sports) | Not applicable |
| Effects | Improves urinary flow and symptoms associated with benign prostatic hyperplasia (BPH) |
| Side effects | Dizziness, orthostatic hypotension, retrograde ejaculation, headache, diarrhea |
| Use in sports | None |
| Manufacturer | Recordati |
| Packing | 30 tabs (4mg/tab) |
Zimaks 400 Bilim
DELETE - Micardis 80 mg Boehringer Ingelheim
Champix Starter Pack Pfizer
FUCIDIN 500 mg Abdi Ibragim
Prograf 5mg Astellas Pharma
Rovamycine 3.000.000 iu Eczacibasi
Fostimon (Merional) 150 IU HMG IBSA 

Reviews
There are no reviews yet.